INJ price jumped 10.24% in 24 hours and traded near $3.30 after Bitnomial launched regulated U.S. futures for Injective. That move gave the token a rare milestone in the American derivatives market. It also pushed traders to reassess Injective’s (INJ) standing among large-cap digital assets. Besides, the rally arrived with stronger derivatives activity, rising open interest, and a fresh technical breakout that shifted attention toward higher resistance levels.
Bitnomial Launch Gives Injective a New Market Catalyst
Bitnomial’s new listing marks an important step for Injective in the U.S. market. The exchange operates as a CFTC-designated contract market. Consequently, Injective now joins a short list of digital assets with a regulated U.S. futures presence.
That list includes Bitcoin, Ethereum, Solana, and XRP. Therefore, the launch places Injective in a more visible position within the broader crypto market. It also gives institutions another regulated path to gain exposure.
The new contracts use monthly expirations and settle in crypto. Traders can post digital assets or USD as margin through Bitnomial Clearinghouse, LLC. Additionally, that structure creates more flexibility than cash-only products.
Institutional access already runs through futures commission merchants. Retail access will follow through Bitnomial’s Botanical platform in the coming weeks. Hence, the launch could widen participation over time.
This development matters because futures markets often shape price discovery. They also help establish a framework that regulators can evaluate more easily. Moreover, a regulated derivatives venue can improve credibility during a cautious market cycle.
INJ Price Reaction Shows Strong Immediate Demand
The market reacted quickly after the listing went live. INJ price climbed from an intraday low of $2.99 to a high of $3.41. It later settled near $3.30, holding most of the day’s gains.
That price action reflected more than a brief spike. Derivatives volume rose 91.75% to $120.10 million over 24 hours. At the same time, open interest increased 27.47% to $62.01 million.
Those numbers suggest new positions entered the market rather than old positions merely closing. Besides, liquidation data showed a clear imbalance during the move. Short liquidations reached $81.96K, while long liquidations stood at $32.82K.
That gap indicates many traders had positioned for further weakness before the breakout. When INJ price moved higher, those bearish bets unwound and added fuel to the advance. Consequently, INJ price gained extra momentum during the session.
Still, the move did not erase every near-term risk. The rejection near $3.41 showed that sellers still defend higher levels. However, buyers kept control of the broader intraday structure.
Institutional Framing Adds a New Layer to the Story
Bitnomial’s leadership tied the listing to Injective’s market structure and network design. The exchange highlighted Injective’s on-chain order book, cross-chain execution, and low transaction costs. Those features support the case for deeper trading activity.
That message goes beyond a single futures product. It suggests that regulated access could become part of Injective’s larger market identity. Moreover, it gives the asset a stronger institutional narrative than it had earlier in this cycle.
The ETF angle adds another layer. Canary Capital has already filed with the SEC for a staked INJ ETF. Therefore, the existence of regulated futures could become relevant if regulators review future spot-related proposals.
Bitcoin and Ethereum set a clear precedent in this area. Regulated futures often appear before spot products gain approval. Consequently, traders now have another reason to track INJ price beyond short-term chart action.
Injective co-founder Eric Chen also described the listing as a sign of demand for institutional-grade access. That view fits the broader push to bring more market participants into the ecosystem. Additionally, it aligns with the network’s effort to expand beyond crypto-native trading circles.
Supply Reduction Supports the Broader Narrative
Injective also delivered another supply-side update this month. Its April Community BuyBack removed 51,000 INJ from circulation. At current pricing, that amount equals roughly $156,000.
That burn came in 4% above March’s 49,000 INJ reduction. The overall size is not that big, but the tendency counts. Constant decline in circulating supply may be used to back sentiment in times of increasing demand.
This factor in itself will not influence price action. Nonetheless, it reinforces the bullish argument alongside expanding access to new markets and ameliorating derivatives data. In addition, the supply cut-off narratives tend to be more popular when the technical framework goes positive.
The timing also helped. The buyback update arrived as Bitnomial’s launch pushed Injective back into the spotlight. Hence, the market received both a structural catalyst and a tokenomics boost within the same window.
Analysts Spot Breakout in INJ Price
Analyst World Of Charts focused on the daily structure. He flagged a confirmed breakout from a multi-month descending wedge. That pattern had capped Injective since its March 2024 all-time high near $52.75.
The wedge reflected a long period of lower highs through 2025 and early 2026. Therefore, the breakout carries more weight than a routine rebound. It suggests that sellers may have lost control of that broader trendline.
Based on the measured move, World Of Charts sees room for a 98% extension above the breakout area. That setup points toward the $5 to $6 zone. Significantly, that target would represent a major recovery from current levels.
Chiefrat highlighted a shorter-term structure. He noted that INJ price has tightened near a key resistance zone around $3.05. That behavior suggests accumulation as buyers continue to defend pullbacks.
According to his view, a breakout above that area could lead to a push toward $3.35. That level now stands as the next nearby barrier. Consequently, traders will likely watch whether volume stays firm on any move higher.
INJ Momentum Improves as Bulls Regain Ground
Momentum indicators paint a mixed picture. The MACD sits near the zero line, which suggests earlier bearish pressure has faded. Additionally, the histogram has narrowed, and the MACD lines have flattened.
INJ/USD 24-hour price chart: Source: TradingView
That does not confirm a strong trend reversal yet. However, it shows that downside momentum has weakened. Consequently, the market now has more room to respond to bullish catalysts.
The latest Balance of Power reading also turned positive. That shift suggests buyers had a slight edge in the most recent session. Still, one reading alone cannot establish a lasting directional move.
Final Take
The first key zone sits between $3.20 and $3.00. Buyers recently stepped in around that region. Therefore, that band now carries added short-term importance.
A break below that area could expose $2.80 next. If selling grows stronger, lower levels could come into play. On the upside, resistance appears near $3.60, followed by a more important level around $4.00.
